432 related articles for article (PubMed ID: 12438234)
1. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia.
Yuen ST; Davies H; Chan TL; Ho JW; Bignell GR; Cox C; Stephens P; Edkins S; Tsui WW; Chan AS; Futreal PA; Stratton MR; Wooster R; Leung SY
Cancer Res; 2002 Nov; 62(22):6451-5. PubMed ID: 12438234
[TBL] [Abstract][Full Text] [Related]
2. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas.
Chan TL; Zhao W; Leung SY; Yuen ST;
Cancer Res; 2003 Aug; 63(16):4878-81. PubMed ID: 12941809
[TBL] [Abstract][Full Text] [Related]
3. Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas.
Fransén K; Klintenäs M; Osterström A; Dimberg J; Monstein HJ; Söderkvist P
Carcinogenesis; 2004 Apr; 25(4):527-33. PubMed ID: 14688025
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression.
Calistri D; Rengucci C; Seymour I; Lattuneddu A; Polifemo AM; Monti F; Saragoni L; Amadori D
J Cell Physiol; 2005 Aug; 204(2):484-8. PubMed ID: 15702478
[TBL] [Abstract][Full Text] [Related]
5. BRAF mutations in aberrant crypt foci and hyperplastic polyposis.
Beach R; Chan AO; Wu TT; White JA; Morris JS; Lunagomez S; Broaddus RR; Issa JP; Hamilton SR; Rashid A
Am J Pathol; 2005 Apr; 166(4):1069-75. PubMed ID: 15793287
[TBL] [Abstract][Full Text] [Related]
6. Frequent involvement of ras-signalling pathways in both polypoid-type and flat-type early-stage colorectal cancers.
Noda H; Kato Y; Yoshikawa H; Arai M; Togashi K; Nagai H; Konishi F; Miki Y
J Exp Clin Cancer Res; 2006 Jun; 25(2):235-42. PubMed ID: 16918136
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of mutations within the kinase activation segment of B-Raf in human colorectal tumors.
Ikenoue T; Hikiba Y; Kanai F; Tanaka Y; Imamura J; Imamura T; Ohta M; Ijichi H; Tateishi K; Kawakami T; Aragaki J; Matsumura M; Kawabe T; Omata M
Cancer Res; 2003 Dec; 63(23):8132-7. PubMed ID: 14678966
[TBL] [Abstract][Full Text] [Related]
8. Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans.
Rosenberg DW; Yang S; Pleau DC; Greenspan EJ; Stevens RG; Rajan TV; Heinen CD; Levine J; Zhou Y; O'Brien MJ
Cancer Res; 2007 Apr; 67(8):3551-4. PubMed ID: 17440063
[TBL] [Abstract][Full Text] [Related]
9. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.
Kambara T; Simms LA; Whitehall VL; Spring KJ; Wynter CV; Walsh MD; Barker MA; Arnold S; McGivern A; Matsubara N; Tanaka N; Higuchi T; Young J; Jass JR; Leggett BA
Gut; 2004 Aug; 53(8):1137-44. PubMed ID: 15247181
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation.
Nagasaka T; Sasamoto H; Notohara K; Cullings HM; Takeda M; Kimura K; Kambara T; MacPhee DG; Young J; Leggett BA; Jass JR; Tanaka N; Matsubara N
J Clin Oncol; 2004 Nov; 22(22):4584-94. PubMed ID: 15542810
[TBL] [Abstract][Full Text] [Related]
11. NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.
Omholt K; Platz A; Kanter L; Ringborg U; Hansson J
Clin Cancer Res; 2003 Dec; 9(17):6483-8. PubMed ID: 14695152
[TBL] [Abstract][Full Text] [Related]
12. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas.
Bläker H; Helmchen B; Bönisch A; Aulmann S; Penzel R; Otto HF; Rieker RJ
Scand J Gastroenterol; 2004 Aug; 39(8):748-53. PubMed ID: 15513360
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy.
Spring KJ; Zhao ZZ; Karamatic R; Walsh MD; Whitehall VL; Pike T; Simms LA; Young J; James M; Montgomery GW; Appleyard M; Hewett D; Togashi K; Jass JR; Leggett BA
Gastroenterology; 2006 Nov; 131(5):1400-7. PubMed ID: 17101316
[TBL] [Abstract][Full Text] [Related]
14. Both BRAF and KRAS mutations are rare in colorectal carcinomas from patients with hereditary nonpolyposis colorectal cancer.
Miyaki M; Iijima T; Yamaguchi T; Kadofuku T; Funata N; Mori T
Cancer Lett; 2004 Jul; 211(1):105-9. PubMed ID: 15194222
[TBL] [Abstract][Full Text] [Related]
15. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer.
Jass JR; Baker K; Zlobec I; Higuchi T; Barker M; Buchanan D; Young J
Histopathology; 2006 Aug; 49(2):121-31. PubMed ID: 16879389
[TBL] [Abstract][Full Text] [Related]
16. Somatic mutations of the APC, KRAS, and TP53 genes in nonpolypoid colorectal adenomas.
van Wyk R; Slezak P; Hayes VM; Buys CH; Kotze MJ; de Jong G; Rubio C; Dolk A; Jaramillo E; Koizumi K; Grobbelaar JJ
Genes Chromosomes Cancer; 2000 Feb; 27(2):202-8. PubMed ID: 10612810
[TBL] [Abstract][Full Text] [Related]
17. Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer.
Oliveira C; Velho S; Domingo E; Preto A; Hofstra RM; Hamelin R; Yamamoto H; Seruca R; Schwartz S
Oncogene; 2005 Nov; 24(51):7630-4. PubMed ID: 16007118
[TBL] [Abstract][Full Text] [Related]
18. Telomerase activity and p53 gene mutation in familial polyposis coli.
Ikeguchi M; Makino M; Kaibara N
Anticancer Res; 2000; 20(5C):3833-7. PubMed ID: 11268463
[TBL] [Abstract][Full Text] [Related]
19. Somatic BRAF-V600E mutations in familial colorectal cancer.
Vandrovcova J; Lagerstedt-Robinsson K; Påhlman L; Lindblom A
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2270-3. PubMed ID: 17119056
[TBL] [Abstract][Full Text] [Related]
20. KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression.
Oliveira C; Velho S; Moutinho C; Ferreira A; Preto A; Domingo E; Capelinha AF; Duval A; Hamelin R; Machado JC; Schwartz S; Carneiro F; Seruca R
Oncogene; 2007 Jan; 26(1):158-63. PubMed ID: 16953233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
